Allorecognition pathways in transplant rejection and tolerance

Area of Science:

• Immunology
• Transplantation Biology
• Cellular Therapy

Background:

• Chronic rejection and late allograft loss necessitate a deep understanding of allorecognition pathways and effector mechanisms.
• Current cellular therapies highlight the need for advanced strategies to improve long-term graft survival.

Purpose of the Study:

• To review current knowledge of T-cell allorecognition pathways in transplantation.
• To discuss mechanisms of allograft rejection and inform future prevention strategies.
• To evaluate the potential of regulatory T cells as a cellular therapy for chronic rejection.

Main Methods:

• Review of existing literature on T-cell allorecognition pathways.
• Analysis of direct and indirect allorecognition pathways in CD4 T cells.
• Discussion of effector mechanisms contributing to chronic allograft rejection.

Main Results:

• Indirect pathway CD4 T cells are the dominant alloreactive T-cell population late after transplantation.
• These cells contribute to chronic rejection and allograft vasculopathy by promoting alloantibody generation.
• Regulatory T cells show potential as an effective cellular therapy.

Conclusions:

• Adoptive therapy with CD4 regulatory T cells, particularly those with indirect allospecificity and ability to inhibit alloantibody responses, is a rational approach to mitigate chronic rejection.
• Targeting indirect allorecognition pathways and alloantibody production is crucial for improving long-term allograft survival.